Rhumatologie

Maintenance of Infliximab Treatment in Ankylosing Spondylitis : results of one-year randomized controlled trial comparing systematic versus on-demand treatment

Arthritis & Rheumatism, Vol. 58, N° 1, January 2008, pp 88-97 Breban M, Ravaud Ph, Claudepierre P, Baron G, Henry Y-D, Hudry C, Euller-Ziegler L, Pham T, Solau-Gervais E, Chary-Valckenaere I, Marcelli C, Perdriger A, Le Loët X; Wendling D, Fautrel B, Fournié B, Combe B, Gaudin Ph, Jousse S, Mariette X, Baleydier A; Trape G, and Dougados M, for the French Ankylosing Spondylitis Infliximab Network.

Vous souhaitez échanger
avec nos équipes

Contactez-nous

D’autres articles qui pourraient
vous intéresser

Impact of disease activity for patients with axial spondyloarthritis
Rhumatologie

Impact of disease activity for patients with axial spondyloarthritis

Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis
Rhumatologie

Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis

Impact of terminating reimbursement of symptomatic slow-acting drugs in osteoarthritis in France
Rhumatologie

Impact of terminating reimbursement of symptomatic slow-acting drugs in osteoarthritis in France